S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Harvest Natural Resources Inc stock logo
HNR
Harvest Natural Resources
$6.62
$0.00
$1.68
$7.35
N/AN/A105,587 shsN/A
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
$1.13
-1.7%
$1.37
$1.09
$3.55
$82.55M0.88330,828 shs421,188 shs
PennyMac Mortgage Investment Trust stock logo
PMT
PennyMac Mortgage Investment Trust
$13.28
+0.3%
$14.06
$10.52
$15.89
$1.15B1.48620,115 shs640,904 shs
WEL
Integrated Wellness Acquisition
$11.45
+0.3%
$11.33
$10.56
$12.41
$81.64M0.0326,313 shs5,901 shs
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Harvest Natural Resources Inc stock logo
HNR
Harvest Natural Resources
0.00%0.00%0.00%0.00%0.00%
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
-0.43%-9.45%-10.85%-22.30%-53.44%
PennyMac Mortgage Investment Trust stock logo
PMT
PennyMac Mortgage Investment Trust
-0.30%-5.19%-6.27%-8.34%+11.50%
WEL
Integrated Wellness Acquisition
-0.09%+0.18%+0.97%+1.87%+8.14%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Harvest Natural Resources Inc stock logo
HNR
Harvest Natural Resources
N/AN/AN/AN/AN/AN/AN/AN/A
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
2.5997 of 5 stars
3.50.00.00.01.10.03.1
PennyMac Mortgage Investment Trust stock logo
PMT
PennyMac Mortgage Investment Trust
3.0381 of 5 stars
1.23.01.70.03.43.33.1
WEL
Integrated Wellness Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Harvest Natural Resources Inc stock logo
HNR
Harvest Natural Resources
N/AN/AN/AN/A
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
3.00
Buy$10.00784.96% Upside
PennyMac Mortgage Investment Trust stock logo
PMT
PennyMac Mortgage Investment Trust
2.40
Hold$14.589.86% Upside
WEL
Integrated Wellness Acquisition
N/AN/AN/AN/A

Current Analyst Ratings

Latest PMT, WEL, PLX, UOG, and HNR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/18/2024
PennyMac Mortgage Investment Trust stock logo
PMT
PennyMac Mortgage Investment Trust
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$15.00
2/7/2024
PennyMac Mortgage Investment Trust stock logo
PMT
PennyMac Mortgage Investment Trust
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$15.00 ➝ $16.00
(Data available from 4/18/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Harvest Natural Resources Inc stock logo
HNR
Harvest Natural Resources
N/AN/AN/AN/AN/AN/A
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
$65.49M1.26$0.14 per share8.35$0.47 per share2.40
PennyMac Mortgage Investment Trust stock logo
PMT
PennyMac Mortgage Investment Trust
$429.02M2.68$2.48 per share5.35$16.34 per share0.81
WEL
Integrated Wellness Acquisition
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Harvest Natural Resources Inc stock logo
HNR
Harvest Natural Resources
N/AN/A0.00N/AN/AN/AN/AN/A
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
$8.31M$0.0522.601.40N/A12.69%29.73%10.17%5/2/2024 (Estimated)
PennyMac Mortgage Investment Trust stock logo
PMT
PennyMac Mortgage Investment Trust
$199.65M$1.618.258.97N/A46.54%14.15%1.45%4/24/2024 (Confirmed)
WEL
Integrated Wellness Acquisition
N/AN/A0.00N/AN/AN/AN/AN/A

Latest PMT, WEL, PLX, UOG, and HNR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/24/2024N/A
PennyMac Mortgage Investment Trust stock logo
PMT
PennyMac Mortgage Investment Trust
$0.32N/A-$0.32N/AN/AN/A  
3/14/2024Q4 2023
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
-$0.03-$0.07-$0.04-$0.07$8.15 million$10.49 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Harvest Natural Resources Inc stock logo
HNR
Harvest Natural Resources
N/AN/AN/AN/AN/A
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
N/AN/AN/AN/AN/A
PennyMac Mortgage Investment Trust stock logo
PMT
PennyMac Mortgage Investment Trust
$1.6012.05%+9.58%99.38%N/A
WEL
Integrated Wellness Acquisition
N/AN/AN/AN/AN/A

Latest PMT, WEL, PLX, UOG, and HNR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/21/2024
PennyMac Mortgage Investment Trust stock logo
PMT
PennyMac Mortgage Investment Trust
Quarterly$0.4010.85%4/11/20244/12/20244/26/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Harvest Natural Resources Inc stock logo
HNR
Harvest Natural Resources
N/AN/AN/A
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
N/A
1.54
1.12
PennyMac Mortgage Investment Trust stock logo
PMT
PennyMac Mortgage Investment Trust
1.37
0.28
0.28
WEL
Integrated Wellness Acquisition
N/AN/AN/A

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Harvest Natural Resources Inc stock logo
HNR
Harvest Natural Resources
N/AN/AN/ANot Optionable
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
20873.05 million69.42 millionOptionable
PennyMac Mortgage Investment Trust stock logo
PMT
PennyMac Mortgage Investment Trust
786.65 million85.87 millionOptionable
WEL
Integrated Wellness Acquisition
N/A7.13 million4.65 millionNot Optionable

PMT, WEL, PLX, UOG, and HNR Headlines

No headlines for this company have been tracked by MarketBeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Harvest Natural Resources logo

Harvest Natural Resources

NYSE:HNR
Harvest Natural Resources, Inc. (Harvest) is in the process of dissolution and winding up. The Company was previously a petroleum exploration and production company. The Company was engaged in acquiring exploration, development and producing properties in geological basins active hydrocarbon systems.
Protalix BioTherapeutics logo

Protalix BioTherapeutics

NYSE:PLX
Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso for the treatment of Gaucher disease; and Elfabrio for the treatment of adult patients with a confirmed diagnosis of Fabry disease. It is also developing PRX-115, a plant cell-expressed recombinant PEGylated Uricase which is in Phase I trial for the treatment of gout; and PRX-119, a plant cell-expressed PEGylated recombinant human DNase I product candidate that is in preclinical phase for the treatment of NETs-related diseases. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz; and Chiesi Farmaceutici S.p.A. The company was incorporated in 1993 and is headquartered in Carmiel, Israel. Protalix BioTherapeutics, Inc. is a subsidiary of Protalix Ltd.
PennyMac Mortgage Investment Trust logo

PennyMac Mortgage Investment Trust

NYSE:PMT
PennyMac Mortgage Investment Trust, through its subsidiary, primarily invests in mortgage-related assets in the United States. The company operates through: Credit Sensitive Strategies, Interest Rate Sensitive Strategies, Correspondent Production segments. Its Credit Sensitive Strategies segment invests in credit risk transfer (CRT) agreements, CRT securities, subordinate mortgage-backed securities (MBS), distressed loans, and real estate. The company's Interest Rate Sensitive Strategies segment engages in investing in mortgage servicing rights, excess servicing spreads, and agency and senior non-agency MBS, as well as related interest rate hedging activities. Its Correspondent Production segment is involved in purchasing, pooling, and reselling newly originated prime credit residential loans directly or in the form of MBS. The company primarily sells its loans to government-sponsored entities or PennyMac Loan Services, LLC. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its shareholders. The company was incorporated in 2009 and is headquartered in Westlake Village, California.

Integrated Wellness Acquisition

NYSE:WEL
Integrated Wellness Acquisition Corp does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the health, nutrition, fitness, wellness, and beauty sectors. Integrated Wellness Acquisition Corp was incorporated in 2021 and is based in Florida, New York.